Shouguang Fukang Pharmaceutical Co.,Ltd
Shouguang Fukang Pharmaceutical Co., Ltd is a high‑tech corporation located in Shandong Province, China. The company positions itself as a manufacturer and exporter of pharmaceutical raw materials and intermediates, with a particular emphasis on bromine compounds. Its product portfolio includes trimethoprim, sulfamethoxazole, hydroxyurea, itraconazole and various intermediates, as well as multiple substituted benzaldehyde derivatives and related brominated compounds. The organization highlights its extensive resources in bromine as a strategic advantage, enabling a broad range of chemical products and custom manufacturing capabilities.
According to available information, the company maintains a focus on research and development, along with a strict quality assurance system. This emphasis on product development and quality control underpins its ability to offer custom manufacturing services for pharmaceutical intermediates and bromine‑based chemical products. The profile notes a substantial output position within its core product lines and an established practice as a manufacturer that integrates raw material supply with production and export activities.
Details on production scale, export markets, regulatory certifications, or specific facility capabilities are not provided in the available profile. The company’s stated operations suggest a vertically integrated model that leverages self‑owned bromine resources to support its manufacturing activities, though explicit data on facilities, capacity, or compliance standards is not described in the provided material.
Overall, Shouguang Fukang Pharmaceutical Co., Ltd presents itself as a specialized chemical and pharmaceutical materials producer with capabilities in the development, production, and international export of API ingredients, intermediates, and bromine compounds, complemented by a stated commitment to research, development, and quality assurance.
